Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 30) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 30) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Advaxis, Inc. (NASDAQ: ADXS ) Alkermes Plc (NASDAQ: ALKS ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Emergent Biosolutions Inc (NYSE: EBS ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Insys Therapeutics Inc (NASDAQ: INSY ) Minerva Neurosciences Inc (NASDAQ: NERV ) Mylan NV (NASDAQ: MYL ) Myovant Sciences Ltd (NYSE: MYOV )(announced $100 million worth of common stock offering) Neuronetics Inc (NASDAQ: STIM ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teligent Inc (NASDAQ: TLGT ) Urogen Pharma Ltd (NASDAQ: URGN ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) Theravance Biopharma Inc (NASDAQ: TBPH ) Zafgen Inc (NASDAQ: ZFGN ) ( reacted to safety concerns over its diabetes drug following the Type A meeting with FDA) Stock In Focus Merrimack Board Decides Against Sale Following Strategic Review Following the completion of a strategic review, Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) said its board has decided to restructure the company such that its …

Read more

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2019 Earnings Conference Call May 09, 2019 08:30 AM ET Company Participants Kate Bechtold - IR Liz Barrett - President and C

Read more

URGN earnings call for the period ending .

Read more

Key events - healthcare (Part 2)
02:52pm, Friday, 26'th Apr 2019

Read more

Smart investors are constantly on the lookout for a bargain when it comes to stock picking. As of late, investors have been taking a second look at shares of UroGen Pharma Ltd. (:URGN). During recent

Read more

Watching some technical levels for Urogen Pharma Ltd (URGN), we have noticed that the current 20-Day Bollinger Bands signal is reading Hold. This indicator may be used to assist with identifying overs

Read more

In trying to determine the current valuation of UroGen Pharma Ltd. (NasdaqGM:URGN) shares, we note that the Book to Market ratio of the shares stands at 0.119109. It’s commonly accepted that a Book

Read more

Investors may be taking a closer look at shares of Urogen Pharma Ltd (URGN). Let us focus in on the current opinion signal on the stock. The opinion signal for the current session is 56% Sell. Looking

Read more

We are comparing VBI Vaccines Inc. (NASDAQ:VBIV) and UroGen Pharma Ltd. (NASDAQ:URGN) on their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation.

Read more

Fujitsu General Limited (TSE:6755) has a Value Composite score of 21. Developed by James O’Shaughnessy, the VC score uses six valuation ratios. These ratios are price to earnings, price to cash flow

Read more

Urogen Pharma Ltd (URGN) are in focus as we look at near-term expected movement. The reading from the 40-day commodity channel index is currently Hold. The CCI indicator is mainly used to identify ove

Read more

Urogen Pharma Ltd Ordinary Shares (URGN) shares are on chartist’s watch as the stock is edging above the MACD Histogram zero line. Current levels place the share price around 36.94, while the MACD i

Read more

Since UroGen Pharma Ltd. (NASDAQ:URGN) and Orchard Therapeutics plc (NASDAQ:ORTX) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the analyst

Read more

Axovant Sciences Ltd. (NASDAQ:AXGT) and UroGen Pharma Ltd. (NASDAQ:URGN) compete with each other in the Biotechnology sector. We will analyze and compare their institutional ownership, profitability,

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank